Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Interest Expenses (2018 - 2025)

TransMedics (TMDX) has 8 years of Interest Expenses data on record, last reported at $3.4 million in Q4 2025.

  • For Q4 2025, Interest Expenses fell 6.08% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $13.8 million, down 4.35%, while the annual FY2025 figure was $13.8 million, 4.35% down from the prior year.
  • Interest Expenses reached $3.4 million in Q4 2025 per TMDX's latest filing, down from $3.5 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $3.6 million in Q2 2024 and bottomed at $787000.0 in Q3 2022.
  • Average Interest Expenses over 5 years is $2.3 million, with a median of $2.9 million recorded in 2023.
  • Peak YoY movement for Interest Expenses: dropped 19.61% in 2022, then surged 356.16% in 2023.
  • A 5-year view of Interest Expenses shows it stood at $978000.0 in 2021, then grew by 2.97% to $1.0 million in 2022, then skyrocketed by 257.99% to $3.6 million in 2023, then dropped by 0.94% to $3.6 million in 2024, then fell by 6.08% to $3.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $3.4 million in Q4 2025, $3.5 million in Q3 2025, and $3.5 million in Q2 2025.